cGMP PROCEDURES FOR DIETARY SUPPLEMENTS, MEDICAL DEVICES OR DRUG PRODUCTS INTENDED FOR HUMAN USE
One of the most common failures cited by FDA inspectors in Warning Letters is the lack of adequate documentation. The FDA wants to see details on how firms make and keep written procedures for specifications, Quality Control operations, Master Manufacturing…